-
Assessing VYVGART Social Media Data in Generalized Myasthenia Gravis To Understand Patient, Caregiver, and HCP Sentiment
Mar 10, 2025, 14:00 PM -
Interventions To Overcome the Challenges for Identifying Substandard, Spurious, Falsely Labeled, Falsified and Counterfeit Drugs (SSFFC).A Systematic Review.
Mar 10, 2025, 14:00 PM -
Cost-Utility analysis of Dinutuximab Beta in Treating High-Risk Neuroblastoma: A Partitioned Survival Model Using R programming Language
Mar 10, 2025, 14:00 PM -
Conceptual Framework for a De Novo Cost-effectiveness Model in Glycogen Storage Disease Type Ia (GSDIa)
Mar 10, 2025, 14:00 PM -
Cost Comparison of Osimertinib Plus Chemotherapy Versus Amivantamab Plus Lazertinib for the First-Line Treatment of Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Treated With First-Line Platinum-Based Chemotherapy (PBC) and =2 Subsequent Lines of Therapy in the United States
Mar 10, 2025, 14:00 PM -
Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population
Mar 10, 2025, 14:00 PM -
The Global Economic Burden of Type 1 Diabetes: Current Estimates and Projections to 2040
Mar 10, 2025, 14:00 PM -
Disparities in Breast Cancer Screening Rates are Compounded by Type of Insurance Coverage and Social Drivers of Health
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Adults 60 Years of Age and Older in Japan
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization in the Management of Patients with Relapse/Refractory Mantle Cell Lymphoma in Canada
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization of Tafamidis Patients in the United States
Mar 10, 2025, 14:00 PM -
Economic Impact of Trastuzumab and Its Biosimilars for the Treatment of HER2-Positive Breast Cancer Patients: A Real-World Study in the US
Mar 10, 2025, 14:00 PM -
A Real-World Retrospective Cohort Study Characterizing Patients with MMN in the United States
Mar 10, 2025, 14:00 PM -
Progression-Free Survival (PFS) as a Surrogate for Overall Survival (OS) in the Front-Line Maintenance Setting for Advanced Ovarian Cancer (OC): A Trial-Level Meta-Analysis
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Disparity on Hospital Outcomes: Review of 5 Diseases and their Unique Challenges
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Sotagliflozin for Patients With Type 1 Diabetes and Chronic Kidney Disease, With and Without Dynamic Pricing
Mar 10, 2025, 14:00 PM -
Economic Burden of Prader-Willi Syndrome Among Pediatric Patients in the United States
Mar 10, 2025, 14:00 PM -
The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective
Mar 10, 2025, 14:00 PM -
Presenteeism in Employees with Chronic Conditions: An Analysis Using Linked Claims and Self-Reported Employee Health Risk Assessment Data
Mar 10, 2025, 14:00 PM
